Go Deep
Haemonetics Corporation
Haemonetics Corporation Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 15,779 | 57.6 | 6.45 | 1.40 | 11,464.08 |
| Oct 2026 | 15,574 | 59.0 | 6.63 | 1.40 | 11,686.09 |
| Oct 2026 | 16,364 | 58.8 | 6.62 | 1.40 | 11,591.85 |
| Oct 2026 | 16,406 | 58.5 | 6.58 | 1.40 | 11,499.09 |
| Oct 2026 | 16,393 | 58.9 | 6.59 | 1.40 | 11,517.82 |
| Oct 2026 | 16,598 | 57.1 | 6.43 | 1.40 | 11,202.88 |
| Oct 2026 | 16,568 | 57.4 | 6.45 | 1.40 | 11,257.55 |
| Oct 2026 | 16,603 | 57.1 | 6.42 | 1.40 | 11,208.25 |
| Oct 2026 | 16,678 | 56.6 | 6.37 | 1.40 | 11,076.52 |
| Oct 2026 | 16,742 | 56.1 | 6.31 | 1.40 | 10,964.44 |
Haemonetics Corporation Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 339,380,000.0 | 346,351,000.0 | 338,967,000.0 | 327,315,000.0 |
| Net Profit | 33,010,000.0 | -20,147,000.0 | 44,740,000.0 | 38,684,000.0 |
| EPS | 0.7 | -0.4 | 1.0 | 0.8 |
Haemonetics Corporation Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 1,334,027,000.0 | 1,360,824,000.0 | 1,309,055,000.0 | 1,168,660,000.0 | — |
| Net Profit | 97,308,000.0 | 167,679,000.0 | 117,558,000.0 | 115,401,000.0 | — |
| EPS | 2.1 | 3.3 | 2.3 | 2.3 | — |
Haemonetics Corporation Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 2,395,925,000.0 | 2,450,948,000.0 | 2,195,591,000.0 | 1,934,825,000.0 | — |
| Total Liabilities | 1,599,605,000.0 | 1,630,112,000.0 | 1,235,632,000.0 | 1,116,828,000.0 | — |
| Total Equity | 796,320,000.0 | 820,836,000.0 | 959,959,000.0 | 817,997,000.0 | — |
Owes vs Owns
Haemonetics Corporation owed $0.65 for every $1 it owned in Jun 2026, up from $0.58 in Mar 2023.
| Period | Jun 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.65× | 0.67× | 0.67× | 0.56× | 0.58× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Haemonetics Corporation Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 10.2%Receivables 9.1%Inventory 12.8%Fixed assets (tangible) 12.8%Intangible assets 46.1%Other assets 9.1%
How it's funded — Mar 2026
Long-term debt 50.9%Payables 2.1%Other liabilities 13.5%Shareholders' equity 33.2%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 24.5 | 30.7 | 17.9 | 28.4 |
| Receivables | 21.7 | 20.3 | 20.7 | 17.9 |
| Inventory | 30.6 | 36.5 | 31.7 | 25.9 |
| Fixed assets (tangible) | 30.6 | 28.4 | 31.1 | 31.1 |
| Intangible assets | 110.4 | 106.0 | 97.1 | 74.2 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 21.7 | 23.2 | 21.0 | 15.9 |
| Liabilities & equity | ||||
| Short-term debt | 0.5 | 30.4 | 1.0 | 1.2 |
| Long-term debt | 122.0 | 92.1 | 79.8 | 75.4 |
| Payables | 5.1 | 6.7 | 7.3 | 6.4 |
| Other liabilities | 32.4 | 33.8 | 35.4 | 28.7 |
| Shareholders' equity | 79.6 | 82.1 | 96.0 | 81.8 |
| Net tangible assets | -30.8 | -23.9 | -1.1 | 7.6 |
Haemonetics Corporation Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 293,221,000.0 | 181,725,000.0 | 181,751,000.0 | 273,058,000.0 | — |
| Investing Activities | -179,547,000.0 | -161,895,000.0 | -322,389,000.0 | -143,788,000.0 | — |
| Financing Activities | -178,460,000.0 | 108,818,000.0 | 38,157,000.0 | -100,364,000.0 | — |